Policy Impact of the Rural Emergency Hospital Designation: A Mixed Methods Study of Leaders’ Conversion Experiences and Motivations
The Journal of Rural Health · 2026-09 · 42 (4)
DOI: 10.1111/jrh.70240 ↗Abstract
Abstract Purpose The Rural Emergency Hospital (REH) designation, effective January 2023, offers financially distressed rural hospitals an alternative to closure to preserve emergency and outpatient services. Little is known about how hospital leaders weigh conversion or navigate its implementation. We characterized the pre‐conversion financial profile of converting hospitals and examined leaders' decision‐making and early implementation experiences. Methods An explanatory sequential mixed‐methods study was utilized. Quantitative analyses drew on a hospital‐year panel (2013–2022) constructed from Medicare Cost Reports, the American Hospital Association Annual Survey, and the American Community Survey, comparing future REH converters with REH‐eligible and REH‐ineligible rural hospitals using one‐way ANOVA. Semi‐structured key informant interviews were conducted July through October 2025 with leaders representing 14 REHs, coded inductively by two investigators to thematic saturation. Findings Before conversion, future REHs had lower days cash on hand, longer accounts receivable cycles, and higher uncompensated care than rural peers, reflecting a sustained multiyear margin decline. Leaders described conversion as a staged process: financial distress prompted consideration; a net‐feasibility analysis weighed the fixed facility payment and enhanced outpatient reimbursement against forgone inpatient, swing‐bed, and 340B revenue; external technical assistance and system affiliation enabled conversion; and implementation surfaced regulatory ambiguity, cross‐payer recognition gaps, payment delays, and the need to sustain community trust. Conclusions REH conversion is a context‐dependent, multistage trade‐off rather than a universal solution. Earlier outreach before reserves are depleted, sustained technical assistance, and clearer regulatory and cross‐payer guidance may strengthen the model as a durable alternative to closure.
EUVIMED